Synvisc-One^® and SYNVISC^® (hylan G-F 20) are covered by the majority of commercial payers, however, you should be aware of patient-specific insurance benefits and plan restrictions.

Before treating a patient with Synvisc-One or SYNVISC, it is recommended that you conduct and insurance verification to understand patient-specific insurance coverage. This will help to assess if Synvisc-One and SYNVISC are covered, whether there is a specialty pharmacy option, whether there are setting-of-care restrictions, and what the patient’s cost-sharing requirements, including deductibles, co-payments, co-insurance, and out-of-pocket maximums are.

SYNVISC Connection can help you understand coverage and coding guidelines for Synvisc-One and SYNVISC under a patient’s commercial insurance.

Providers retain responsibility for determining reimbursement and insurance issues related to their patients. Genzyme cannot be responsible for failure of a provider to obtain reimbursement.